Insider Transactions in Q1 2025 at Tango Therapeutics, Inc. (TNGX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Douglas Barry General Counsel |
SELL
Open market or private sale
|
Direct |
2,556
-3.73%
|
$7,668
$3.16 P/Share
|
|
Feb 05
2025
|
Daniella Beckman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,948
-2.56%
|
$11,844
$3.16 P/Share
|
|
Feb 05
2025
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
6,851
-4.15%
|
$20,553
$3.16 P/Share
|
|
Feb 05
2025
|
Barbara Weber Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,013
-0.55%
|
$27,039
$3.16 P/Share
|
|
Feb 04
2025
|
Douglas Barry General Counsel |
SELL
Open market or private sale
|
Direct |
2,774
-3.89%
|
$5,548
$2.99 P/Share
|
|
Feb 04
2025
|
Daniella Beckman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,284
-2.7%
|
$8,568
$2.99 P/Share
|
|
Feb 04
2025
|
Adam Crystal |
SELL
Open market or private sale
|
Direct |
7,432
-4.31%
|
$14,864
$2.99 P/Share
|
|
Feb 04
2025
|
Barbara Weber Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,778
-0.6%
|
$19,556
$2.99 P/Share
|
|
Feb 03
2025
|
Daniella Beckman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,119
+14.15%
|
-
|
|
Feb 03
2025
|
Douglas Barry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
27,363
+27.72%
|
-
|
|
Feb 03
2025
|
Barbara Weber Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,875
+6.06%
|
-
|
|
Feb 03
2025
|
Adam Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
53,015
+23.51%
|
-
|